CRSP Crispr Therapeutics AG

$70.19

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 10/6/2025

About Crispr Therapeutics AG

CRISPR Therapeutics AG, a gene editing company, focuses on the development of gene-based transformative drugs for serious human diseases. The company is headquartered in Zug, Switzerland.

Website: https://www.crisprtx.com

Sector
LIFE SCIENCES
Industry
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1674416
Address
BAARERSTRASSE 14, ZUG, CH
Valuation
Market Cap
$3.26B
P/E Ratio
nan
PEG Ratio
-0.21
Price to Book
1.69
Performance
EPS
$-4.34
Dividend Yield
—
Profit Margin
0.00%
ROE
-19.20%
Technicals
50D MA
$41.04
200D MA
$46.09
52W High
$67.88
52W Low
$30.04
Fundamentals
Shares Outstanding
86M
Target Price
$82.38
Beta
1.84

CRSP EPS Estimates vs Actual

● Estimated
● Actual

CRSP News & Sentiment

Oct 03, 2025 • Zacks Commentary SOMEWHAT-BULLISH
CRISPR Therapeutics AG ( CRSP ) Stock Falls Amid Market Uptick: What Investors Need to Know
CRISPR Therapeutics AG (CRSP) reached $67.74 at the closing of the latest trading day, reflecting a -6.98% change compared to its last close.
Sep 26, 2025 • Zacks Commentary SOMEWHAT-BULLISH
CRISPR Therapeutics AG ( CRSP ) Laps the Stock Market: Here's Why
In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $61.67, marking a +2.24% move from the previous day.
Sep 23, 2025 • Zacks Commentary NEUTRAL
CRISPR Therapeutics AG ( CRSP ) Falls More Steeply Than Broader Market: What Investors Need to Know
In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $60.62, marking a -2.38% move from the previous day.
Sep 23, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Is Trending Stock CRISPR Therapeutics AG ( CRSP ) a Buy Now?
CRISPR Therapeutics (CRSP) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Sep 22, 2025 • GlobeNewswire NEUTRAL
CRISPR Therapeutics and Sirius Therapeutics Announce First Patient Dosed in Phase 2 Trial of SRSD107 for Thromboembolic Disorders in Europe
ZUG, Switzerland and BOSTON and SAN DIEGO and SHANGHAI, Sept. 22, 2025 ( GLOBE NEWSWIRE ) -- CRISPR Therapeutics ( NASDAQ: CRSP ) , a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, and Sirius Therapeutics, a clinical stage biotech company ...
Sep 22, 2025 • Benzinga NEUTRAL
CRISPR Therapeutics and Sirius Therapeutics Announce First Patient Dosed in Phase 2 Trial of SRSD107 for Thromboembolic Disorders in Europe - CRISPR Therapeutics ( NASDAQ:CRSP )
ZUG, Switzerland and BOSTON and SAN DIEGO and SHANGHAI, Sept. 22, 2025 ( GLOBE NEWSWIRE ) -- CRISPR Therapeutics CRSP, a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, and Sirius Therapeutics, a clinical stage biotech company developing ...
Sentiment Snapshot

Average Sentiment Score:

0.138
50 articles with scored sentiment

Overall Sentiment:

Neutral

CRSP Reported Earnings

Feb 11, 2025
Dec 31, 2024 (Post market)
0.75 Surprise
  • Reported EPS: $-0.44
  • Estimate: $-1.19
  • Whisper: —
  • Surprise %: 62.9%
Nov 04, 2024
Sep 30, 2024 (Post market)
0.41 Surprise
  • Reported EPS: $-1.01
  • Estimate: $-1.42
  • Whisper: —
  • Surprise %: 28.9%
Aug 05, 2024
Jun 30, 2024 (Post market)
0.03 Surprise
  • Reported EPS: $-1.49
  • Estimate: $-1.52
  • Whisper: —
  • Surprise %: 2.0%
May 08, 2024
Mar 31, 2024 (Post market)
-0.1 Surprise
  • Reported EPS: $-1.43
  • Estimate: $-1.33
  • Whisper: —
  • Surprise %: -7.5%
Feb 21, 2024
Dec 31, 2023 (Pre market)
1.17 Surprise
  • Reported EPS: $1.10
  • Estimate: $-0.07
  • Whisper: —
  • Surprise %: 1671.4%
Nov 06, 2023
Sep 30, 2023 (Post market)
0.54 Surprise
  • Reported EPS: $-1.41
  • Estimate: $-1.95
  • Whisper: —
  • Surprise %: 27.7%
Aug 07, 2023
Jun 30, 2023 (Post market)
1.14 Surprise
  • Reported EPS: $-0.98
  • Estimate: $-2.12
  • Whisper: —
  • Surprise %: 53.8%
May 08, 2023
Mar 31, 2023 (Post market)
1.03 Surprise
  • Reported EPS: $-0.67
  • Estimate: $-1.70
  • Whisper: —
  • Surprise %: 60.6%
Feb 21, 2023
Dec 31, 2022 (Post market)
0.89 Surprise
  • Reported EPS: $-1.41
  • Estimate: $-2.30
  • Whisper: —
  • Surprise %: 38.7%

Financials